#Anhedonia - the inability to feel pleasure - is a core symptom of major depressive disorder and remains challenging to treat. The phase 2 #TERPSIS study evaluated NBI-1065846, a novel experimental #GPR139 #agonist targeting the #lateral #habenula.

🔗 Read more: journals.lww.com/psychopharma...